MorphoSys AG ADR buy Stakeholder
Start price
05.08.20
/
50%
€29.00
Target price
04.11.21
-
Performance (%)
-62.07%
End price
17.08.21
€11.00
Summary
This prediction ended on 17.08.21 with a price of €11.00. Massive losses of -62.07% were the result for the BUY prediction by Stakeholder. Stakeholder has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG ADR | - | - | - | - |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% | 63.917% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% | 91.986% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% | 83.957% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% | 71.357% |
Comments by Stakeholder for this prediction
In the thread Morphosys AG diskutieren
Zulassung des Krebsmedikamentes Monjuvi in den USA

